# IMMIX BIOPHARMA INC (IMMX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IMMX/

- Reporting holders: 3
- Reported value: $8.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $5.1K | 492 | 0.0% | 1 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $3.5K | 335 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $10 | 1 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $8.6K |
| Q2 2026 | 110 | $620.1M |
| Q1 2026 | 77 | $248.0M |
| Q4 2025 | 68 | $128.2M |
| Q3 2025 | 31 | $5.8M |
| Q2 2025 | 23 | $4.7M |
| Q1 2025 | 22 | $4.9M |
| Q4 2024 | 23 | $6.4M |
| Q3 2024 | 26 | $6.1M |
| Q2 2024 | 29 | $8.8M |
| Q1 2024 | 34 | $16.1M |
| Q4 2023 | 27 | $5.4M |